Cited by 14Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental DisordersSchizophrenia research and treatment

Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage

Open access
Woo, Young Jae, Kanellopoulos, Alexandros K., Hemati, Parisa, Kirschen, Jill, Nebel, Rebecca A., Wang, Tao, Bagni, Claudia, Abrahams, Brett S.·2019·Biological Psychiatry

Abstract

Background Deletions encompassing a four-gene region on chromosome 15 (BP1-BP2 at 15q11.2), seen at a population frequency of 1 in 500, are associated with increased risk for schizophrenia, epilepsy, and other common neurodevelopmental disorders. However, little is known in terms of how these common deletions impact cognition. Methods We used a Web-based tool to characterize cognitive function in a novel cohort of adult carriers and their noncarrier family members. Results from 31 carrier and 38 noncarrier parents from 40 families were compared with control data from 6530 individuals who self-registered on the Lumosity platform and opted in to participate in research. We then examined aspects of sensory and cognitive function in flies harboring a mutation in Cyfip, the homologue of one of the genes within the deletion. For the fly studies, 10 or more groups of 50 individuals per genotype were included. Results Our human studies revealed profound deficits in grammatical reasoning, arithmetic reasoning, and working memory in BP1-BP2 deletion carriers. No such deficits were observed in noncarrier spouses. Our fly studies revealed deficits in associative and nonassociative learning despite intact sensory perception. Conclusions Our results provide new insights into outcomes associated with BP1-BP2 deletions and call for a discussion on how to appropriately communicate these findings to unaffected carriers. Findings also highlight the utility of an online tool in characterizing cognitive function in a geographically distributed population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2019.04.008

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among the four genes (TUBGCP5, CYFIP1, NIPA2, and NIPA1) in the 15q11.2 region, increasing evidence highlights the relevance of CYFIP1.

    “Among the four genes (TUBGCP5, CYFIP1, NIPA2, and NIPA1) encompassed within this narrow region, increasing evidence highlights the relevance of CYFIP1109.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. [1]Hashemi B, Bassett A, Chitayat D, Chong K, Feldman M, Flanagan J, (2015): Deletion of 15q11.2(BP1-BP2) region: Further evidence for lack of phenotypic specificity in a pediatric population. Am J Med Genet Part A. 167: 2098– 2102. 25946043
  2. [2]Stefansson H, Rujescu D, Cichon S, Pietiläinen OPH, Ingason A, Steinberg S, (2008): Large recurrent microdeletions associated with schizophrenia. Nature. 455: 232– 6. 18668039 PMC2687075
  3. [3]Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, (2014): CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 505: 361– 6. 24352232
  4. [4]Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, (2009): Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 18: 1497– 1503. 19181681 PMC2664144
  5. [5]Grozeva D, Conrad DF, Barnes CP, Hurles M, Owen MJ, O’Donovan MC, (2012): Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res. 135: 1– 7. 22130109 PMC3315675
  6. [8]Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, (2011): A copy number variation morbidity map of developmental delay. Nat Genet. 43: 838– 846. 21841781 PMC3171215
  7. [9]Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, Shafer N, (2009): A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res. 19: 1579– 85. 19506092 PMC2752120
  8. [10]Cafferkey M, Ahn JW, Flinter F, Ogilvie C (2014): Phenotypic features in patients with 15q11.2(BP1-BP2) deletion: Further delineation of an emerging syndrome. Am J Med Genet A. 2. doi: 10.1002/ajmg.a.36554. 24715682 · DOI · Paper page
  9. [11]Murthy SKK, Nygren a. OHOH, El Shakankiry HMM, Schouten JPP, Al Khayat a. II, Ridha A, (2007): Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res. 116: 135– 40. 17268193
  10. [14]Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, (2011): Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 130: 517– 28. 21359847 PMC6814187
  11. [15]Abdelmoity AT, LePichon J-B, Nyp SS, Soden SE, Daniel CA, Yu S (2012): 15q11.2 Proximal Imbalances Associated With a Diverse Array of Neuropsychiatric Disorders and Mild Dysmorphic Features. J Dev Behav Pediatr. 33: 570– 576. 22922608
  12. [16]Vanlerberghe C, Petit F, Malan V, Vincent-delorme C, Duban B, Vallee L, (2015): 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: A series of 52 patients. Eur J Med Genet. 1– 8. 25596525
  13. [18]Silva AI, Ulfarsson MO, Stefansson H, Gustafsson O, Walters GB, Linden DEJ, (2018): Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study. Biol Psychiatry.. doi: 10.1016/j.biopsych.2018.11.004. PMC6424871 30583851 · DOI · Paper page
  14. [20]Schenck A, Bardoni B, Langmann C, Harden N, Mandel JL, Giangrande A (2003): CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron. 38: 887– 898. 12818175
  15. [22]Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL (2001): A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci U S A. 98: 8844– 9. 11438699 PMC37523
  16. [23]Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, (2008): The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell. 134: 1042– 54. 18805096
  17. [24]Panja D, Kenney JW, D’Andrea L, Zalfa F, Vedeler A, Wibrand K, (2014): Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK. Cell Rep. 9: 1430– 45. 25453757
  18. [25]Santini E, Huynh TN, Longo F, Koo SY, Mojica E, D’Andrea L, (2017): Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice. Sci Signal. 10. doi: 10.1126/scisignal.aan0665. PMC5858943 29114037 · DOI
  19. [26]Oguro-Ando A, Rosensweig C, Herman E, Nishimura Y, Werling D, Bill BR, (2014): Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR. Mol Psychiatry.. doi: 10.1038/mp.2014.124. PMC4409498 25311365 · DOI · Paper page
  20. [29]Bozdagi O, Sakurai T, Dorr N, Pilorge M, Takahashi N, Buxbaum JD (2012): Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. PLoS One. 7: e42422. 22900020 PMC3416859
  21. [31]Dominguez-Iturza N, Shah D, Vannelli A, Lo AC, Armendariz M, Li KW, (2018): The autism and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity. bioRxiv. 477174. PMC6672001 31371726
  22. [32]Silva AI, Haddon JE, Trent S, Syed YA, Lin T-CE, Patel Y, (2018): Cyfip1 haploinsufficiency is associated with white matter changes, myelin thinning, reduction of mature oligodendrocytes and behavioural inflexibility. bioRxiv. 477786.
  23. [33]Hirayama-Kurogi M, Takizawa Y, Kunii Y, Matsumoto J, Wada A, Hino M, (2017): Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics. J Proteomics. 158: 31– 42. 28214564
  24. [34]Noroozi R, Omrani MD, Sayad A, Taheri M, Ghafouri-Fard S (2018): Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. Metab Brain Dis.. doi: 10.1007/s11011-018-0249-8. 29752658 · DOI
  25. [35]Sayad A, Ranjbaran F, Ghafouri-Fard S, Arsang-Jang S, Taheri M (2018): Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients. J Mol Neurosci. 65: 336– 342. 29992499
  26. [36]Zhao Q, Li T, Zhao X, Huang K, Wang T, Li Z, (2012): Rare CNVs and Tag SNPs at 15q11.2 Are Associated With Schizophrenia in the Han Chinese Population. Schizophr Bull.. doi: 10.1093/schbul/sbr197. PMC3627771 22317777 · DOI · Paper page
  27. [37]Wang J, Tao Y, Song F, Sun Y, Ott J, Saffen D (2015): Common Regulatory Variants of CYFIP1 Contribute to Susceptibility for Autism Spectrum Disorder (ASD) and Classical Autism. Ann Hum Genet. 329– 340. 26094621
  28. [38]Nebel RA, Zhao D, Pedrosa E, Kirschen J, Lachman HM, Zheng D, Abrahams BS (2016): Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks. PLoS One. 11: e0148039. 26824476 PMC4732616
  29. [39]Murphy SM, Preble a M, Patel UK, O’Connell KL, Dias DP, Moritz M, (2001): GCP5 and GCP6: two new members of the human gamma-tubulin complex. Mol Biol Cell. 12: 3340– 3352. 11694571 PMC60259
  30. [40]Izumi N, Fumoto K, Izumi S, Kikuchi A (2008): GSK-3β regulates proper mitotic spindle formation in cooperation with a component of the γ-tubulin ring complex, GCP5. J Biol Chem. 283: 12981– 12991. 18316369
  31. [41]Xiong Y, Oakley BR (2009): In vivo analysis of the functions of gamma-tubulin-complex proteins. J Cell Sci. 122: 4218– 27. 19861490 PMC2776505
  32. [42]Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004): Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 36: 131– 7. 14745448
  33. [43]Freyberg Z, Ferrando SJ, Javitch JA (2010): Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry. 167: 388– 96. 19917593 PMC3245866
  34. [44]Hur E-M, Zhou F-Q (2010): GSK3 signalling in neural development. Nat Rev Neurosci. 11: 539– 51. 20648061 PMC3533361
  35. [45]Maver A, Čuturilo G, Kovanda A, Miletić A, Peterlin B (2018): Rare missense TUBGCP5 gene variant in a patient with primary microcephaly. Eur J Med Genet.. doi: 10.1016/j.ejmg.2018.12.003. 30543990 · DOI
  36. [46]Goytain A, Hines RM, El-Husseini A, Quamme GA (2007): NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem. 282: 8060– 8. 17166836
  37. [47]Rainier S, Chai J-H, Tokarz D, Nicholls RD, Fink JK (2003): NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet. 73: 967– 71. 14508710 PMC1180617
  38. [48]Dekker AM, Seelen M, van Doormaal PTC, van Rheenen W, Bothof RJP, van Riessen T, (2016): Large-scale screening in sporadic amyotrophic lateral sclerosis identifies genetic modifiers in C9orf72 repeat carriers. Neurobiol Aging. 39: 220.e9– 15. 26777436
  39. [49]Tazelaar GHP, Dekker AM, van Vugt JJFA, van der Spek RA, Westeneng H-J, Kool LJBG, (2019): Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. Neurobiol Aging. 74: 234.e9– 234.e15. PMC7893598 30342764
  40. [50]Jiang Y, Zhang Y, Zhang P, Sang T, Zhang F, Ji T, (2012): NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet. 131: 1217– 24. 22367439
  41. [51]Xie H, Zhang Y, Zhang P, Wang J, Wu Y, Wu X, (2014): Functional Study of NIPA2 Mutations Identified from the Patients with Childhood Absence Epilepsy. PLoS One. 9: e109749. 25347071 PMC4209971
  42. [53]Nyholt DR (2004): A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 74: 765– 9. 14997420 PMC1181954
  43. [54]Pavlopoulos E, Anezaki M, Skoulakis EMC (2008): Neuralized is expressed in the alpha/beta lobes of adult Drosophila mushroom bodies and facilitates olfactory long-term memory formation. Proc Natl Acad Sci U S A. 105: 14674– 9. 18794519 PMC2567224
  44. [55]Moressis A, Friedrich AR, Pavlopoulos E, Davis RL, Skoulakis EMC (2009): A dual role for the adaptor protein DRK in Drosophila olfactory learning and memory. J Neurosci. 29: 2611– 25. 19244537 PMC2693346
  45. [56]Kanellopoulos AK, Semelidou O, Kotini AG, Anezaki M, Skoulakis EMC (2012): Learning and memory deficits consequent to reduction of the fragile X mental retardation protein result from metabotropic glutamate receptor-mediated inhibition of cAMP signaling in Drosophila. J Neurosci. 32: 13111– 24. 22993428 PMC6621471
  46. [57]Acevedo SF, Froudarakis EI, Tsiorva A-A, Skoulakis EMC (2007): Distinct neuronal circuits mediate experience-dependent, non-associative osmotactic responses in Drosophila. Mol Cell Neurosci. 34: 378– 89. 17197197
  47. [58]Acevedo SF, Froudarakis EI, Kanellopoulos A, Skoulakis EMC (2007): Protection from premature habituation requires functional mushroom bodies in Drosophila. Learn Mem. 14: 376– 84. 17522029 PMC1876762
  48. [59]Rosenthal DG, Learned N, Liu YH, Weitzman M (2013): Characteristics of fathers with depressive symptoms. Matern Child Health J. 17: 119– 128. 22362259
  49. [60]Taylor JL, Warren ZE (2012): Maternal depressive symptoms following autism spectrum diagnosis. J Autism Dev Disord. 42: 1411– 1418. 21965086
  50. [61]Bjornsdottir G, Halldorsson JG, Steinberg S, Hansdottir I, Kristjansson K, Stefansson H, Stefansson K (2014): The Adult Reading History Questionnaire (ARHQ) in Icelandic: Psychometric Properties and Factor Structure. J Learn Disabil. 47: 532– 42. 23456983
  51. [62]Woo YJ, Wang T, Guadalupe T, Nebel RA, Vino A, Del Bene VA, (2016): A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus. PLoS One. 11: e0158036. 27351196 PMC4924813
  52. [63]Ruscio J, Mullen T (2012): Confidence Intervals for the Probability of Superiority Effect Size Measure and the Area Under a Receiver Operating Characteristic Curve. Multivariate Behav Res. 47: 201– 23. 26734848
  53. [64]Kemper MB, Hagerman RJ, Ahmad RS, Mariner R (1986): Cognitive profiles and the spectrum of clinical manifestations in heterozygous fra (X) females. Am J Med Genet. 23: 139– 56. 3953643
  54. [65]Miezejeski CM, Jenkins EC, Hill AL, Wisniewski K, French JH, Brown WT (1986): A profile of cognitive deficit in females from fragile X families. Neuropsychologia. 24: 405– 9. 3736823
  55. [66]Rivera SM, Menon V, White CD, Glaser B, Reiss AL (2002): Functional brain activation during arithmetic processing in females with fragile X Syndrome is related to FMR1 protein expression. Hum Brain Mapp. 16: 206– 18. 12112763 PMC6872022

Cited by

Sorted by citations

Authors
Woo, Y. J., Kanellopoulos, A. K., Hemati, P., Kirschen, J., Nebel, R. A., Wang, T., Bagni, C., & Abrahams, B. S.
Affiliations
  • Albert Einstein College of Medicine (US)
  • University of Lausanne (CH)
  • University of Rome Tor Vergata (IT)
Corresponding author
Abrahams, Brett S.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2019-08
Volume
86
Issue
4
Pages
306-314
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2939420829
Cited by
14
References
11
Citations by year
2025: 2 · 2024: 2 · 2023: 3 · 2021: 1 · 2020: 5 · 2019: 1
FWCI
1.04
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Lirias (submittedVersion, other-oa)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • National Center for Advancing Translational Sciences
  • National Center for Research Resources
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institutes of Health
  • Autism Speaks
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
CYFIP1, cognitive impairment, working memory, arithmetic reasoning, grammatical reasoning, associative learning, non-associative learning, sensory perception, Drosophila, neurodevelopmental disorders, schizophrenia, epilepsy, Lumosity, online cognitive assessment
MeSH terms
Adult, Animals, Chromosome Aberrations, Chromosomes, Human, Pair 15, Drosophila, Female, Genotype, Humans, Male, Middle Aged, Phenotype, Cohort Studies, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Cognitive Dysfunction, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review